entertainment -WSS

entertainment

author：entertainment 2025-09-30 22:04:52 - browse：63286

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： At JPM 2024, hospital systems pitch financial strength to investors

hotspot

WSS

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Covid misinformation case heads to Supreme Court

Does Paxlovid work in people vaccinated against Covid

SAMSHA loosens regulations on methadone treatment centers

SAMSHA loosens regulations on methadone treatment centers

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

hotspot

entertainment

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Does Paxlovid work in people vaccinated against Covid

Hepatitis C has a cure — but many Americans still lack access to it

Physician assistants need a new name. Here's what it should be

Medical leaders decry Supreme Court decision on affirmative action

New Ultima Genomics DNA sequencer can read genome for $100

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

American taxpayers paid $1.8 trillion in health care costs in 2022

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

hotspot

Vertex non

Medicare drug price negotiation’s day in court

ARCH Venture Partners is raising $3 billion for a life sciences fund

Medicare Advantage coverage denials need scrutiny, senators say

At JPM 2024, hospital systems pitch financial strength to investors

Medicare drug price negotiation’s day in court

leisure time

hotspot

hotspot

explore